{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:27:34Z","timestamp":1788362854348,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejphar.2023.175821","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T02:02:18Z","timestamp":1685412138000},"page":"175821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Nattokinase prevents \u03b2-amyloid peptide (A\u03b21-42) induced neuropsychiatric complications, neuroinflammation and BDNF signalling disruption in mice"],"prefix":"10.1016","volume":"952","author":[{"given":"Shivraj","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Katariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Shelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Patravale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkishor","family":"Kotagale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2023.175821_bib1","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s12035-016-9795-4","article-title":"Neuroprotective effect of fisetin against amyloid-beta-induced cognitive\/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175821_bib2","first-page":"876","article-title":"Miracle enzymes serrapeptase and nattokinase mitigate neuroinflammation and apoptosis associated with Alzheimer's disease in experimental model","volume":"3","author":"Ahmed","year":"2013","journal-title":"WJPPS"},{"issue":"50","key":"10.1016\/j.ejphar.2023.175821_bib3","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jpi.12238","article-title":"Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3\/Akt\/GSk3\u03b2 pathway in the mouse hippocampus","volume":"59","author":"Ali","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2023.175821_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/srep11708","article-title":"Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus","volume":"5","author":"Ali","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10787-017-0381-9","article-title":"Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer's disease by fermented soybean nanoneutraceutical","volume":"26","author":"Bhatt","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.ejphar.2023.175821_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1006\/nbdi.2001.0451","article-title":"Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells","volume":"8","author":"Blasko","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175821_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2009.10.006","article-title":"Inflammation, microglia, and Alzheimer's disease","volume":"37","author":"Cameron","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.ejphar.2023.175821_bib9","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/jf000020k","article-title":"Potent fibrinolytic enzyme from a mutant of Bacillus subtilis IMR-NK1","volume":"48","author":"Chang","year":"2000","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175821_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-6-22","article-title":"Replication by the epistasis project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease","author":"Combarros","year":"2009","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.ejphar.2023.175821_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","article-title":"Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease","volume":"66","author":"Cortes-Canteli","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ejphar.2023.175821_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/JAD-2012-120820","article-title":"Fibrinogen and altered hemostasis in Alzheimer's disease","volume":"32","author":"Cortes-Canteli","year":"2012","journal-title":"J. Alzheim. Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175821_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cns.12484","article-title":"Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer's disease and dementia with Lewy bodies","volume":"22","author":"Cummings","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2023.175821_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135447","article-title":"Evidences for agmatine alterations in A\u03b21-42induced memory impairment in mice","volume":"740","author":"Dixit","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175821_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00702-003-0055-1","article-title":"Neuroinflammatory perspectives on the two faces of Alzheimer's disease","volume":"111","author":"Eikelenboom","year":"2004","journal-title":"J. Neural. Transm."},{"issue":"49","key":"10.1016\/j.ejphar.2023.175821_bib17","doi-asserted-by":"crossref","first-page":"75086","DOI":"10.1007\/s11356-022-21126-9","article-title":"Nattokinase attenuates bisphenol A or gamma irradiation-mediated hepatic and neural toxicity by activation of Nrf2 and suppression of i nflammatory mediators in rats","volume":"29","author":"Elbakry","year":"2022","journal-title":"Environ. Sci. Pollut. Control Ser."},{"issue":"7407","key":"10.1016\/j.ejphar.2023.175821_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41398-020-00928-w","article-title":"The cholinesterase inhibitor donepezil has antidepressant-like properties in the mouse forced swim test","volume":"10","author":"Fitzgerald","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2023.175821_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0268-9499(95)80005-0","article-title":"Characterization of nattokinase degraded products from human fibrinogen or cross-linked fibrin","volume":"9","author":"Fujita","year":"1995","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.ejphar.2023.175821_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jep.2015.09.025","article-title":"Pharmacological validation of in-silico guided novel nootropic potential of Achyranthe saspera L","volume":"175","author":"Gawande","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175821_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneumeth.2005.06.009","article-title":"ELISA methods to measure cholinergic markers and nerve growth factor receptors in cortex, hippocampus, prefrontal cortex, and basal forebrain from rat brain","volume":"150","author":"Gearhart","year":"2006","journal-title":"J. Neurosci. Methods"},{"issue":"10","key":"10.1016\/j.ejphar.2023.175821_bib23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.65.10.1193","article-title":"Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study","author":"Geda","year":"2008","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175821_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/jf803072r","article-title":"Amyloid-degrading ability of nattokinase from Bacillus subtilisnatto","volume":"57","author":"Hsu","year":"2009","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175821_bib25","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.62.6.25","article-title":"Nattokinase attenuates retinal neovascularization via modulation of Nrf2\/HO-1 and glial activation","volume":"62","author":"Huang","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2023.175821_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fneur.2017.00102","article-title":"Alzheimer's disease: biomarkers in the genome, blood, and cerebrospinal fluid","volume":"8","author":"Huynh","year":"2017","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175821_bib27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","article-title":"Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons","volume":"1862","author":"Kapasi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"19","key":"10.1016\/j.ejphar.2023.175821_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910637","article-title":"Donepezil regulates LPS and A\u03b2-stimulated neuroinflammation through MAPK\/NLRP3 inflammasome\/STAT3 signaling","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175821_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172976","article-title":"Agmatine reverses memory deficits induced by A\u03b21\u201342 peptide in mice: a key role of imidazoline receptors","volume":"196","author":"Kotagale","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2023.175821_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2023.175821_bib32","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","author":"Lim","year":"2000","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175821_bib33","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer's disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.ejphar.2023.175821_bib34","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study","volume":"88","author":"Lyketsos","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2023.175821_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.175821_bib36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer's disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2023.175821_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11481-011-9331-2","article-title":"Chronic IL-1\u03b2-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration","volume":"7","author":"Matousek","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175821_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2023.175821_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175821_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2023.175821_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2013.00129","article-title":"Regulation of adaptive immunity; the role of interleukin-10","volume":"4","author":"Ng","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.175821_bib42","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20070304","article-title":"Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease","volume":"204","author":"Paul","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.175821_bib43","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"issue":"3","key":"10.1016\/j.ejphar.2023.175821_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175821_bib45","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1042\/BST20140155","article-title":"Astrocytes and neuroinflammation in Alzheimer's disease","volume":"42","author":"Phillips","year":"2014","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175821_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0014-2999(79)90507-7","article-title":"Forced swimming in rats: hypothermia, immobility and the effects of imipramine","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00465-0","article-title":"Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology","volume":"16","author":"Rahman","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease","volume":"39","author":"Rojo","year":"2008","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12035-015-9674-4","article-title":"Endogenous Apolipoprotein E (ApoE) fragmentation is linked to amyloid pathology in transgenic mouse models of Alzheimer's disease","volume":"54","author":"Saul","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175821_bib50","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neurobiolaging.2014.09.019","article-title":"Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model","volume":"36","author":"Schmole","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.ejphar.2023.175821_bib51","article-title":"The contact activation system and vascular factors as alternative targets for Alzheimer's disease therapy","volume":"5","author":"Singh","year":"2021","journal-title":"Res. Practice Thrombosis Haemost."},{"issue":"10","key":"10.1016\/j.ejphar.2023.175821_bib52","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/BF01956052","article-title":"A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet","volume":"43","author":"Sumi","year":"1987","journal-title":"Experientia"},{"issue":"6","key":"10.1016\/j.ejphar.2023.175821_bib53","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0002-9440(10)63269-5","article-title":"Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease","volume":"165","author":"Sung","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.ejphar.2023.175821_bib54","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/jcbfm.2015.76","article-title":"Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease","volume":"35","author":"Sweeney","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"12","key":"10.1016\/j.ejphar.2023.175821_bib55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2146\/ajhp050509","article-title":"Nattokinase for prevention of thrombosis","volume":"63","author":"Tai","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2008.07.007","article-title":"New insights into brain BDNF function in normal aging and Alzheimer disease","volume":"59","author":"Tapia-Arancibia","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"27","key":"10.1016\/j.ejphar.2023.175821_bib57","doi-asserted-by":"crossref","first-page":"24690","DOI":"10.1074\/jbc.M101751200","article-title":"The profibrinolytic enzyme subtilis in NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1","volume":"276","author":"Urano","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175821_bib58","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175821_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ejphar.2023.175821_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00018-007-7288-3","article-title":"Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions","volume":"65","author":"Wang","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2023.175821_bib61","doi-asserted-by":"crossref","first-page":"E523","DOI":"10.3390\/ijms18030523","article-title":"Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease","volume":"18","author":"Weng","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175821_bib62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2008-15401","article-title":"Animal models of Alzheimer's disease: therapeutic implications","volume":"15","author":"Woodruff-Pak","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"20","key":"10.1016\/j.ejphar.2023.175821_bib63","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and depositionin an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175821_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000252817","article-title":"Nattokinase promoted tissue plasminogen activator release from human cells","volume":"36","author":"Yatagai","year":"2008","journal-title":"Pathophysiol. Haemostasis Thrombosis"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923003321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923003321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:18:52Z","timestamp":1757978332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923003321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":63,"alternative-id":["S0014299923003321"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175821","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nattokinase prevents \u03b2-amyloid peptide (A\u03b21-42) induced neuropsychiatric complications, neuroinflammation and BDNF signalling disruption in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175821"}}